Light and ultrasound reveal renewable routes to compounds for pharmaceutical research

Renewable routes to pharmaceutical compounds are being explored through the use of light and ultrasound in combination with lignin, a major byproduct of wood processing. This innovative approach, demonstrated by two recent studies from the Colmenares group at IPC PAS, could reduce dependence on fossil feedstocks, high temperatures, and metal catalysts.

In the first study, researchers transformed coniferyl alcohol, derived from lignin, into dehydrodiconiferyl alcohol (DHCA) with 100% substrate conversion and 54% selectivity under optimized conditions. This reaction was carried out using a metal-free catalyst activated by light, while ultrasound produced microscopic bubbles that generated localized energy without exposing the entire system to extreme heat. The ultrasound's intensity and distribution were found to influence the selectivity of the reaction.

In the second study, scientists created a metal-free catalyst from lignin and chitosan, a material obtained from chitin in sources like crustacean shells. This catalyst was used to combine two acetovanillone molecules, yielding diapocynin with over 97% selectivity and a 33% yield. Diapocynin is being studied for its potential in limiting damaging reactive oxygen species in disease models.

Both studies represent laboratory proofs of concept and do not yet represent finished medicines or industrial processes. However, they demonstrate the potential for better utilization of local biological resources, reduced reliance on scarce metals and fossil feedstocks, and more precise processes for pharmaceutical research and specialty chemistry. Further work is needed to optimize yield and scale-up these methods for practical use.